Genomics in catch-up mode

Genomics has been considered one of the hottest sectors in biotech for the past year or more. Certainly, companies engaged in the discovery of genes and the elucidation of gene function have put together rich deals with pharmaceutical companies, including transactions in the past month between Human Genome Sciences and partner SmithKline Beechham with several other pharma companies...